Apolipoprotein B testing for screening, diagnosis, and management of dyslipidemia and cardiovascular disease
HAYES, Inc.
Record ID 32004000355
English
Authors' objectives:
Apolipoprotein B (apo B) testing is proposed for the screening, diagnosis, and management of dyslipidemia and cardiovascular disease (CVD) in healthy persons who may be at risk for CVD, as well as those with established disease. Since apo B is the major apolipoprotein associated with low-density lipoprotein cholesterol (LDL-C), it has been suggested that apo B can provide information regarding CVD risk in addition to that provided by more common lipid tests.
Authors' methods:
Review
Details
Project Status:
Completed
URL for project:
http://www.hayesinc.com/
Year Published:
2000
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Apolipoproteins B
- Cardiovascular Diseases
- Hyperlipidemias
- Mass Screening
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.